7DUN
Crystal structure of Fab fragment of Daratumumab
Experimental procedure
| Experimental method | MAD |
| Source type | SYNCHROTRON |
| Source details | SSRF BEAMLINE BL17U |
| Synchrotron site | SSRF |
| Beamline | BL17U |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2020-09-23 |
| Detector | DECTRIS EIGER2 X 16M |
| Wavelength(s) | 0.9798 |
| Spacegroup name | P 65 2 2 |
| Unit cell lengths | 89.905, 89.905, 217.477 |
| Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
| Resolution | 31.258 - 1.607 |
| R-factor | 0.2056 |
| Rwork | 0.205 |
| R-free | 0.21790 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 4cmh |
| Data reduction software | HKL-2000 |
| Data scaling software | HKL-2000 |
| Phasing software | PHENIX |
| Refinement software | PHENIX (1.14_3260) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 50.000 | 1.640 |
| High resolution limit [Å] | 1.600 | 1.600 |
| Rmerge | 0.100 | |
| Number of reflections | 68212 | 68212 |
| <I/σ(I)> | 30.5 | |
| Completeness [%] | 100.0 | |
| Redundancy | 17 | |
| CC(1/2) | 0.996 | 0.996 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | EVAPORATION, RECRYSTALLIZATION | 291 | 0.2M Potassium phosphate monobasic, 20% w/v Polyethylene glycol 3350 |






